ArticleNature communications2024

Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer.

Shankha S Chatterjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.